about
The use of reconstructed human epidermis for skin absorption testing: Results of the validation studyPulmonary surfactant is indispensable in order to simulate the in vivo situationThe interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticlesEmbryonic chicken trachea as a new in vitro model for the investigation of mucociliary particle clearance in the airwaysVisualization and quantification of polymer distribution in microcapsules by confocal laser scanning microscopy (CLSM).Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa.Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate.TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing.Laser ablation patterning by interference induces directional cell growth.Oral endotracheal intubation of rats for intratracheal instillation and aerosol drug delivery.16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-1.Multiphoton microscopy for the investigation of dermal penetration of nanoparticle-borne drugs.In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.Human vascular endothelial cells in primary cell culture for the evaluation of nanoparticle bioadhesion.Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.Nortriptyline for smoking cessation: release and human skin diffusion from patches.Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier.Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol.Cellular delivery of polynucleotides by cationic cyclodextrin polyrotaxanes.Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.Developments in the area of bioadhesive drug delivery systems.Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing.Lectin-mediated drug targeting: history and applications.Computational modeling of the sugar-lectin interaction.Penetration of topically applied nanocarriers into the hair follicles of dog and rat dorsal skin and porcine ear skin.The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport.Cell culture models of the respiratory tract relevant to pulmonary drug delivery.miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity.Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucusAssessment of mucoadhesion by a resonant mirror biosensor.Nanoparticles for transcutaneous vaccination.Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers.Nanoparticle geometry and surface orientation influence mode of cellular uptake.Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient complianceParticle based vaccine formulations for transcutaneous immunizationInhalative nanomedicine--opportunities and challenges.Pulmonary drug delivery: medicines for inhalation.Influence of particle size and material properties on mucociliary clearance from the airways.Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa.
P50
Q28282521-36192310-78E1-45B2-900C-4311782A9292Q28396472-2219AE47-A0DD-4155-8559-CA2DDB1403BFQ28481207-963C775B-1D28-402A-B154-711947CE02EAQ30497327-8488D329-96C2-4C3E-AB5A-FB456685E8BFQ30646649-FFC97948-FF45-47B8-9D8E-FCE056358EDBQ30693675-07EE5519-689D-4FAD-B6B1-16616DBFECDCQ30829692-EF64C06D-E12C-4643-A4C9-66FD5F88B50DQ31027704-DC30C76A-1E0A-4759-BBC9-EF99E3445C87Q31113395-575FD634-2814-4F24-BBD1-797BA3C4297CQ33182241-F9BA497A-F9D6-4789-BB15-D2659AFA7D48Q33186944-B3090920-49CA-4DE0-9B70-FB473C1AA8EDQ33243957-096C38A4-C1C4-4590-B025-D93CB539650EQ33256336-903B6CC6-4452-4583-8E13-7A9D722CC313Q33260721-60A65A74-880C-40FE-A1F0-49B5133B16D8Q33370590-7A18DA5C-6BD0-48F1-BFF7-5B49425AC030Q33462177-8D0DE73B-C02D-4C4B-8914-D9CBCD6539D1Q33495449-B952D542-9B35-4565-A49F-B3384D7D6EC3Q33740437-67A319F0-888D-4996-89B8-9AC19C8E0564Q34008088-20FF25AF-C1CA-42DB-9DD7-53187F276791Q34334660-B0E70835-9C24-489B-BF2C-F6E02DFBF686Q34467606-DA78E6FA-0CAD-4B65-A14F-3BA77E8A3BA3Q34560671-905D8A1C-3DBA-4DF8-BFA1-BDCB6D9DA62AQ35074029-3F7C8A65-CD10-41F3-83E1-8D737E6C40FFQ35669905-A315D9A6-7E02-4C5B-9BB9-9FDA1A6DDAB5Q35669908-D7523EDB-2698-4124-BF5B-AB13F4B49FF7Q36031215-AB462C3A-9858-4175-B0C1-A8CE75B94910Q36137742-ED80E0FD-6093-4EC8-8CEB-80F12CE1B689Q36168298-263C6886-EBD2-47B9-8981-95F6D6C3669DQ36176908-9DC6059D-FB27-4651-8E70-7CE4E12260AFQ36389587-769DEA71-B537-41B8-B306-4060C1103CE5Q36564181-2D4C7FE4-D555-4C6B-AF14-A7B64C3C628CQ37274692-E4E9F4E2-6688-4D25-991B-0EBE47EE57ABQ37360665-3B791056-EE45-40C6-A576-5C8936501EE5Q37386292-1CCC65B9-524E-48F6-A804-9F4903DD6A36Q37469233-60423B70-F902-4314-95D4-892BE06B9263Q37530378-740DA4E1-0AE0-4741-BAC2-CE2959E8903FQ37532479-E3C3619B-744E-46E8-ACD0-06EEE4C20B47Q37706299-F2C11158-0741-4EA4-8187-5DF76C67B24DQ37760522-4A2C4AA2-44CF-4090-AC28-D58D0A284C22Q37981482-306A682D-8273-41BD-A4DB-A4AE809F62EE
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Claus-Michael Lehr
@ast
Claus-Michael Lehr
@en
Claus-Michael Lehr
@es
Claus-Michael Lehr
@nl
Claus-Michael Lehr
@sl
type
label
Claus-Michael Lehr
@ast
Claus-Michael Lehr
@en
Claus-Michael Lehr
@es
Claus-Michael Lehr
@nl
Claus-Michael Lehr
@sl
prefLabel
Claus-Michael Lehr
@ast
Claus-Michael Lehr
@en
Claus-Michael Lehr
@es
Claus-Michael Lehr
@nl
Claus-Michael Lehr
@sl
P1006
P214
P1006
P1053
A-8174-2014
P106
P1153
7005400498
P21
P214
P31
P3829
P3835
claus-michael-lehr2
P496
0000-0002-5864-8462
P7859
lccn-n99041569